Acorda Therapeutics, Inc. (ACOR) Misses Q1 EPS by 10c, Reaffirms FY11 Guidance
Tweet Send to a Friend
Acorda Therapeutics, Inc. (NASDAQ: ACOR) reported Q1 non-GAAP EPS of $0.08, $0.10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE